Literature DB >> 22487791

The management of drooling in adults with neurological conditions.

Nina Squires1, Adrian Wills, John Rowson.   

Abstract

PURPOSE OF REVIEW: Drooling is a distressing symptom for adults with neurological conditions and can be challenging for health professionals. This review will consider the physical and psychosocial impact of drooling and will discuss the current management options including behavioural, pharmacological and surgical approaches. RECENT
FINDINGS: A number of studies describe the use of botulinum toxin injections and irradiation of the salivary glands but no conclusive guidelines exist to recommend the most efficient dose or technique. The majority of saliva management studies focus on children with physical and/or cognitive disabilities and this evidence cannot be generalized to adults. There are relatively few studies that focus on saliva management in the adult neurological population.
SUMMARY: Drooling is distressing for patients and their families. Ideally an individual would have easy access to the most efficient treatment with the fewest side effects. More evidence is now available but a lack of consensus on management approach, treatment dose and administration technique still exists. The symptom of drooling is best managed by a multidisciplinary team, starting with a conservative approach and then leading to more invasive procedures as appropriate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487791     DOI: 10.1097/MOO.0b013e32835328ec

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  8 in total

1.  The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders.

Authors:  María T Gómez-Caravaca; María T Cáceres-Redondo; Ismael Huertas-Fernández; Laura Vargas-González; Fátima Carrillo; Manuel Carballo; Pablo Mir
Journal:  Neurol Sci       Date:  2014-09-20       Impact factor: 3.307

2.  Frequency and factors related to drooling in Chinese patients with multiple system atrophy: a cross-sectional study.

Authors:  Yalan Chen; Hongyan Huang; Pingping Ning; Quanzhen Zhao; Hui Wang; Qiuyan Shen; Yanming Xu
Journal:  Clin Auton Res       Date:  2019-03-12       Impact factor: 4.435

3.  Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea.

Authors:  Pierangelo Barbero; Marco Busso; Carlo Alberto Artusi; Stefania De Mercanti; Marco Tinivella; Andrea Veltri; Luca Durelli; Marinella Clerico
Journal:  J Vis Exp       Date:  2016-11-09       Impact factor: 1.355

Review 4.  Palliative care in neonatal neurology: robust support for infants, families and clinicians.

Authors:  M E Lemmon; M Bidegain; R D Boss
Journal:  J Perinatol       Date:  2015-12-10       Impact factor: 2.521

5.  Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.

Authors:  Pierangelo Barbero; Marco Busso; Marco Tinivella; Carlo Alberto Artusi; Stefania De Mercanti; Angele Cucci; Andrea Veltri; Paolo Avagnina; Andrea Calvo; Adriano Chio'; Luca Durelli; Marinella Clerico
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

6.  Radiation of parotid or submandibular glands is effective for drooling in patients with parkinsonism; a randomised double-blind placebo-controlled trial.

Authors:  R J H M Steenbakkers; S P van Doornik; A Vissink; W Kerdijk; T van Laar
Journal:  Clin Park Relat Disord       Date:  2022-02-14

Review 7.  Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Authors:  Amanda Amrita Lakraj; Narges Moghimi; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2013-05-21       Impact factor: 4.546

8.  Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

Authors:  Jin-Sun Jun; Han Gil Seo; Soon-Tae Lee; Kon Chu; Sang Kun Lee
Journal:  Ann Clin Transl Neurol       Date:  2017-09-26       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.